TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News GSK advances in Hepatitis B cure with FDA’s fast track for bepirovirsen In a significant development for the treatment of chronic hepatitis B (CHB), GSK plc (LSE/NYSE: GSK) has announced… byPallavi MadhirajuFebruary 13, 2024